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Abstract
Background: Type 2 diabetes mellitus (DM) is responsible for a significant reduction in the quality of life due to its
negative impact on functional capacity. Cardiopulmonary fitness impairment in DM patients has been associated
with limited tissue oxygenation. Phototherapy is widely utilized to treat several disorders due to expected light-
tissue interaction. This type of therapy may help to improve muscular oxygenation, thereby increasing aerobic
fitness and functional capacity.
Methods/Design: This study is a randomized, double-blind, placebo-controlled crossover trial approved by the
Ethics Committee of the Federal University of São Carlos and registered at ClinicalTrials.gov. Four separate tests
will be performed to evaluate the acute effect of phototherapy. All participants will receive both interventions in
random order: light-emitting diode therapy (LEDT) and placebo, with a minimum 14-day interval between sessions
(washout period). Immediately after the intervention, participants will perform moderate constant workload cycling
exercise corresponding to 80 % of the pulmonary oxygen uptake p _VO2
 
during the gas exchange threshold (GET).
LEDT will be administered with a multidiode cluster probe (50 GaAIA LEDs, 850 ηm, 75 mW each diode, and 3 J per
point) before each exercise session. Pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure
will be measured using a computerized metabolic cart, a near-infrared spectrometer, an electrocardiogram, and a
photoplethysmography system, respectively.
Discussion: The main objective of this study is to evaluate the acute effects of muscular pre-conditioning using
LED phototherapy on pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure dynamics
during dynamic moderate exercise. We hypothesize that phototherapy may be beneficial to optimize aerobic
fitness in the DM population. Data will be published after the study is completed.
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Background
Type 2 diabetes (DM) is a significant health problem
worldwide due to its high prevalence and mortality [1].
It is characterized by hyperglycemia caused by defects in
insulin secretion and/or insulin action. DM is associated
with many well-known chronic comorbidities and com-
plications that compromise many tissues, especially the
blood vessels, heart, and nerves [2].
Individuals with DM have reduced aerobic fitness
characterized by lower peak pulmonary oxygen uptake
p _VO2
 
[3–6]. In addition, p _VO2 kinetics analysis has
been used to characterize p _VO2 dynamics during sub-
maximal exercise transitions [5, 7]. The p _VO2 kinetics
during exercise transitions are related to the cardiorespi-
ratory system’s ability to offer O2 and the capacity of the
exercising muscle to utilize this O2 [5, 7]. DM patients
have delayed p _VO2 response after the onset of light to
moderate exercise [5, 8] and premature muscular fatigue
[9] in comparison with a control group. Many potential
mechanisms could explain these impaired responses, for
example, reduced muscle blood flow [10] and capillary
density [11], defects in muscular oxygen diffusion, and
lower mitochondrial oxygen utilization [5] and function
[9, 12, 13].
Phototherapy is a widely used resource due to its effect
on biological tissues, potentially improving muscular effi-
ciency and aerobic fitness [14–18]. Studies with animals
have shown enhanced mitochondrial function [19, 20],
microcirculation, and tissue oxygenation [21, 22] mediated
by phototherapy. Additionally, studies with healthy
humans demonstrate improvements in muscular function,
fatigue resistance, p _VO2 , and exercise tolerance [17, 23]
and decreased concentrations of lactate and muscle
damage markers [23–26].
DM patients have an impaired ability to deliver oxy-
gen (O2) to the muscle and possibly to use this O2
during exercise, which leads to an imbalance between
muscle blood flow and p _VO2 [27], resulting in ham-
pered p _VO2 dynamics. Therefore, the main aim of this
study is to evaluate the acute effects of LED photo-
therapy on muscle oxygenation and p _VO2 kinetics in
individuals with DM during moderate cycling exercise.
We hypothesize that phototherapy will promote thera-
peutic effects such as improved aerobic fitness, which
could ultimately lead to better functional capacity.
Methods/Design
Design
This study is a randomized, double-blind, placebo-
controlled crossover trial approved by the Ethics Com-
mittee of Federal University of São Carlos (number
13573013.1.0000.5504) and registered at ClinicalTrials.-
gov under Trial Number NCT01889784. This study will
be conducted in accordance with the human research
standards set out by the National Health Council Reso-
lution 196/96. The subjects will be included in the study
after providing written informed consent.
The subjects will be divided into two groups: DM
group (DMG) and healthy group (HG). After screening,
the subjects of both groups who meet the eligibility cri-
teria will be randomly allocated to one of two subgroups
(A and B) as described in Fig. 1a. Four separate tests will
be conducted to evaluate the acute effect of photother-
apy. All subjects will receive both interventions, light-
emitting diode therapy (LEDT) and placebo, with a
minimum 14-day interval between sessions (washout
period). The subgroups will determine the intervention
order because the interventions will be alternated in
each visit (Fig. 1b). The subjects in subgroup A will re-
ceive LEDT in the first and third sessions and placebo in
the second and fourth sessions. Subjects in subgroup B
will receive the reverse order. The researcher responsible
for the randomization process will also prepare the
LEDT device (effective or placebo) before each visit and
will not analyze the data.
Subjects
All subjects must be free of overt coronary disease, and
they must be between 40 and 64 years of age. DM indi-
viduals must have a diagnosis according to the recom-
mendations of the American Diabetes Association [2].
The groups will be matched by age and body mass index
(BMI). To achieve that, we will first screen and test the
DMG, then evaluate the control group matching age
and BMI.
Exclusion criteria are BMI > 35 kg/m2, high-sensitivity
C-reactive protein (hs-CRP) > 3.0 mg/L, smoking, anemia,
alcoholism, use of anti-inflammatory or inhalable drugs,
known respiratory and inflammatory diseases, congestive
heart failure, and disability conditions that preclude exer-
cise. Healthy subjects will be excluded if they have direct
family members with DM.
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Sample characterization
Glycohemoglobin (HbA1c), fasting plasma insulin level,
fasting plasma glucose, plasma concentration of CRP,
and lipid profile will be measured after 10 to 12 hours
of fasting using the analyzer ADVIA 1800 Chemistry
System (Siemens, Tarrytown, NY, USA). The degree of in-
sulin resistance will be determined at baseline by the
homeostasis model assessment of insulin resistance
(HOMA-IR), according to the formula: HOMA-IR = fast-
ing plasma insulin (μU/ml) x fasting plasma glucose
(mmol/L)/22.5 [28]. Body composition will be evaluated
by tetrapolar bioelectrical impedance analysis (model BC-
558, Tanita Corporation of America Inc., Arlington
Heights, IL, USA) which calculates body fat, total body
water, muscle mass, visceral fat, and bone mass. The sub-
jects will be required to avoid eating and drinking for
4 hours and to urinate prior to the assessment.
Protocol
Following the screening session, the subjects will return
to the laboratory on 5 different days (Fig. 2). They will
be asked to avoid alcohol and caffeine and refrain from
exercise for 24 hours before testing. All tests will take
place in the morning, at the same time of the day.
On the first day, incremental exercise on a cycloerg-
ometer (Quinton Corival 400, Seattle, WA, USA) will
be performed to determine the gas exchange threshold
(GET) and peak p _VO2 . Subjects should maintain a
cycling cadence of approximately 60 rpm. The work-
load increment will be determined for each subject in
accordance with Wasserman et al. [29]. The GET will
be determined by three independent observers accord-
ing to the ventilatory method [29]. The peak p _VO2
will be the mean p _VO2 value of the last 30 seconds dur-
ing the incremental exercise. It will be assumed that peak
p _VO2 has been achieved when the respiratory exchange
ratio (RER) at exercise peak reaches a value higher than
1.1 [30].
After that, the subjects will return to the laboratory
four more times to receive the muscular pre-
conditioning intervention (LEDT or placebo) accord-
ing to the randomization. Immediately after the
Fig. 1 Study design flowchart. Screening and group/subgroup allocation are described in a. The intervention order of the study is described in b.
DMG, diabetes mellitus group; HG, healthy group
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intervention, the subjects will perform moderate con-
stant workload cycling exercise corresponding to 80 %
of the p _VO2 during the GET. The LEDT will be ad-
ministered with a multidiode cluster probe (50 GaAIA
LEDs, 850 ηm, 75 mW each diode, and 3 J per point)
before each exercise session. The probe will be in dir-
ect contact with skin bilaterally for 40 seconds, deliv-
ering 150 J of total energy to each quadriceps and
triceps surae muscle. Placebo will follow the same pro-
cedure, but, the LEDT device will be turned off.
The constant workload exercise protocol will be pre-
ceded by a resting period and 3 minutes of freewheel
pedaling. Afterwards, 6 minutes of exercise at target
workload will be performed followed by a 6-minute
cool-down period of freewheel pedaling.
Measurements
The p _VO2, carbon dioxide output (pVCO2), minute ven-
tilation (VE), and respiratory exchange rate (RER) will
be measured breath-by-breath using a computerized
metabolic cart (Vmax29c, Sensor Medics, Yorba Linda,
CA, USA) previously calibrated for each session.
Electrocardiography (ECG) will be continuously re-
corded (CM5 lead) with a bioamplifier (BioAmp Power
Lab, ADInstruments, Castle Hill, NSW, Australia) and a
data acquisition system (Power Lab, ADInstruments,
Castle Hill, NSW, Australia). Heart rate (HR) will be esti-
mated based on the ECG signal. Finger arterial pressure
will be measured using a photoplethysmography system
(Finometer Pro, Finapres Medical System, Amsterdam,
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Fig. 2 Experimental protocol flowchart. LEDT, light-emitting diode therapy
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finger of the left hand. To correct the hydrostatic pressure
changes related to the heart, a height correction will be
used as recommended by the manufacturer [31].
Local tissue oxygenation of the vastus lateralis and
gastrocnemius medialis of the right leg will be measured
using near-infrared spectroscopy (NIRS) (Oxymon,
Artinis Medical Systems, Nijmegen, Netherlands). NIRS
provides measurements of changes in concentrations of
deoxygenated and oxygenated hemoglobin (HHb and
O2Hb, respectively). In addition, the tissue saturation
index (TSI) will be measured. To avoid any motion
artifact and ambient light influences, the probe will be
fixed by tape and then a dark cloth will be gently
wrapped around the thigh and calf region.
Before and after the constant workload exercise protocol,
blood samples will be collected via earlobe puncture in
order to verify lactate and glucose using an automated
glucose analyzer (YSI 2300 STAT PLUS – Yellow Springs
Instruments, Yellow Springs, OH, USA) that has been pre-
viously calibrated according to the manufacturer's
instructions.
Data analysis procedures
The p _VO2 and NIRS data collected during constant
workload exercise will be submitted to time domain
kinetics analysis as previously described [5, 32–34]. The
data obtained in the two repetitions of the same con-
stant workload protocol for each intervention (LEDT or
placebo) will be time-aligned and second-by-second in-
terpolated; then, the point-by-point mean between tests
will be finally submitted to kinetics analysis.
Statistical analysis
The data will be expressed as mean and standard devi-
ation values. The Kolmogorov-Smirnov and Levene tests
will be used to test the data for Gaussian distribution and
variance, respectively. The statistics analysis will be per-
formed using two-way repeated-measures ANOVA and a
post hoc Tukey test for intergroup, intragroup, and mul-
tiple comparisons. The level of significance will be set at
5 % (p < 0.05). The statistical power will be set at 0.80,
which is the minimal value recommended in the literature
to minimize type II error.
Discussion
The chronic effect of phototherapy has been widely
studied and shows promising results related to increased
peak p _VO2 , reduction in fatigue, and lactate and C-
reactive protein concentrations [23, 24–26]. This novel
therapeutic tool is generally studied in healthy partici-
pants [17, 18, 23, 25, 26]; however, the acute effects of
phototherapy are still unknown in DM and its impact on
p _VO2 dynamics still needs further clarification.
The effects of LEDT could be beneficial to the DM popu-
lation because the exercise intolerance of this population
decreases quality of life and further increases cardiovascular
risk. Therefore, the purpose of this randomized clinical trial
is to evaluate the acute effects of LEDT on p _VO2 dynamics
in subjects with DM and healthy age- and sex-matched sub-
jects. The results will elucidate the effects of LEDT and may
support the use of this therapy in individuals with DM.
Data will be published after the study is completed.
Trial status
Patient recruitment is currently underway.
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